BRIDGEWATER - Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced the U.S. launch of expanded parameters for Biotrue ONEday for Astigmatism daily disposable contact lenses.
The expansion will increase the toric parameter range by more than 60 percent, offering eye care professionals and their astigmatic patients the largest parameter offering of any daily disposable toric lens.1
'We are proud to offer expanded parameters for Biotrue ONEday for Astigmatism lenses, further deepening our already robust toric lens portfolio as we continue to build upon our eye health offerings,' said Joe Gordon, U.S. president, Bausch + Lomb. 'We are uniquely positioned to support a broad spectrum of vision needs for our customers' patients, including those with astigmatism, a large patient population with unique requirements that can be more challenging to fit.'
'With the additional parameters of Biotrue ONEday for Astigmatism lenses, more of my patients will be able to experience the benefits that this toric lens offers, including all-day comfort and convenience,' said Mile Brujic, O.D., Premier Vision Group, Bowling Green, OH. 'Finding a solution for patients with astigmatism was once a barrier. However, given the advancements in technology and the expansion of parameters such as those seen in Biotrue ONEday for Astigmatism lenses, we can now provide patients the comfort and quality of vision they expect and deserve with a daily disposable toric lens.'
Similar to the other products in the Biotrue ONEday brand family, Biotrue ONEday for Astigmatism lenses are formulated with a patented dehydration barrier, which allows the lens to maintain nearly 100 percent of its moisture for a full 16 hours.1 Biotrue ONEday for Astigmatism contact lenses also offer an evolved peri-ballast design, featuring a tapered edge to limit lid interaction, and spherical aberration control to help reduce halos and glare, particularly in low light conditions.
About Bausch + Lomb
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.
Forward-looking Statements
This news release may contain forward-looking statements which may generally be identified by the use of the words 'anticipates,' 'expects,' 'intends,' 'plans,' 'should,' 'could,' 'would,' 'may,' 'believes,' 'estimates,' 'potential,' 'target,' or 'continue' and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Bausch Health's most recent annual or quarterly report and detailed from time to time in Bausch Health's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Contact:
Arthur Shannon
Email: arthur.shannon@bauschhealth.com
BAUSCH HEALTH COMPANIES INC. 
